maximizing Oncology Research with Integrated KRAS Assay expert services and RAS Assays
within the fast evolving field of oncology analysis, correct and economical mutation screening is important for developing qualified therapies. The KRAS expert services Platform performs a pivotal position With this landscape by offering in depth alternatives for KRAS mutation profiling and analysis. KRAS mutations, found in roughly ninety five% of